CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Adjusts Damora Therapeutics Price Target to $40 From $35, Maintains Outperform Rating

Positive
AI Analysis

Summary

Wedbush raised its price target for Damora Therapeutics from $35 to $40 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingoutperform
Related Companies

Read the original article

Published by yahoo_finance on July 29, 2026 2:34 PM

Read Original